Submission of Manuscript.
One original and three copies of both the
manuscript and all illustrative material, should be submitted to:
Yoshiki Miyachi, M.D., Ph.D.
Journal of Dermatological Science,
Editor-in-Chief
Professor and Chairman
Department of Dermatology
Kyoto University Graduate School of Medicine
54 Kawahara-cho, Shogoin, Sakyo-ku
Kyoto 606-8507, Japan
Tel:+81-75-751-3310 Fax:+81-75-761-3002
E-mail:jds@kuhp.kyoto-u.ac.jp
The entire manuscript should be typed double-spaced, including the Abstract,
footnotes, references, legends and tables, with 3-cm margins.
An accompanying letter should indicate the name, address, telephone and
fax numbers of the corresponding author.
Electronic manuscripts.
Electronic manuscripts have the advantage that there is no need for the
rekeying of text, thereby avoiding the possibility of introducing errors and
resulting in reliable and fast delivery of proofs. For the initial
submission of manuscripts for consideration, hardcopies are sufficient. For
the rapid processing of accepted papers, electronic versions are preferred.
After final acceptance, your disk plus three final and exactly matching
printed versions should be submitted together. Double density (DD) or High
density (HD) diskettes (3 1/2 or 5 1/4 inch) are acceptable. It is important
that the file saved is in the native format of the wordprocessor program
used. Label the disk with the name of the computer and wordprocessing
package used, your name, and the name of the file on the disk. Further
information may be obtained from the Publisher.
Manuscripts.
All manuscripts are subject to editorial review. Papers are classified
according to the following criteria:
1. Original basic and clinical research articles.
2. Review articles: A specific field is reviewed through classical and
up-dated literature. Review articles are usually invited: however, submitted
review articles will be considered. An abstract is required.
3. Speculative articles: Authors can submit their papers as speculative
articles with or without their own data, provided that they offer new
directions contributing to the development.
4. Negative valuable data: The Journal will also provide a new vehicle for
manuscripts which communicate negative but valuable results in order for
other scientists to preform further research in the related field.
5. Short communications: The manuscript must not exceed two printed
Journal
pages (approximately 6 typed pages, including all written material,
figures,
tables and references). A letter stating that this manuscript is a Short
communication must accompany the manuscript.
6. Manuscripts submitted as a rapid communication van be evaluated ad
published as quickly as possible. The manuscript must be no larger than 4
printed pages, and should contain results of high priority, and will be
evaluated by higher standards than regular papers.
7. Letters to the Editor: Appropriate subjects are welcomed. They should
not exceed one printed page. Comments may be solicited from the original
authors. All Letters to the Editor are subject to editing. All manuscripts
must be typed in English. Basic and clinical scientific studies should be
organized as follows: Title Page, Abstract, Introduction, Materials and
Methods, Results, Discussion, Acknowledgements, References, Legends,
Tables and Figures. All pages should be numbered consecutively starting
with the
title page as page one. Trade names must have an initial capital; the
trivial name for a compound may be used if the formal, chemical name (as
established by international convention) is given after the first use.
Authors in Japan please note: Upon request, Elsevier science Japan will
provide authors with a list of people who can check and improve the English
of their paper (before submission). Please contact our Tokyo office:
Elsevier Science Japan, 9-15 Higashi-Azabu 1-chome, Minato-ku, Tokyo
106, Japan; Tel: (03) 5561 5032: Fax: (03) 5561 5045
